Alzheimer's Disease International (ADI) is the worldwide federation of over 100 Alzheimer and dementia associations that support people with dementia and their families in their respective countries. ADI's vision is prevention, care and inclusion today, and cure tomorrow. They work to raise global awareness, influence policy, and promote research and best practices in dementia care and support. ADI is in official relations with the World Health Organization (WHO) and has consultative status with the United Nations (UN).
Serves as the central administrative and coordinating hub for the global federation, managing international advocacy, global awareness campaigns, member relations, research dissemination, and strategic partnerships.
Strategically located in central London, facilitating international collaborations and engagement with global health organizations and policymakers. The office is equipped to support its global communication and coordination role.
A mission-driven, collaborative, and international environment focused on global advocacy, support for member associations, and advancing the cause of people living with dementia and their carers. The culture emphasizes expertise, compassion, evidence-based approaches, and global impact.
The headquarters is the operational core of the leading global voice on dementia, coordinating efforts across its member associations in over 100 countries and influencing global health policy related to Alzheimer's disease and other dementias.
ADI maintains a significant global presence through its federation of member Alzheimer and dementia associations in over 100 countries. Globally, ADI supports functions such as: coordinating international advocacy efforts (e.g., at the WHO and UN), spearheading global awareness campaigns like World Alzheimer's Month, publishing the influential World Alzheimer Report, fostering research collaboration and knowledge exchange, developing and promoting best practices in dementia care and support, and strengthening the capacity of its member associations. ADI also convenes a major annual international conference.
1st Floor, 80-84 Bondway
London
England
United Kingdom
Address: Various locations worldwide (ADI is a federation of over 100 independent national member associations)
Each member association addresses the specific needs and cultural context of dementia care, support, research, and policy within its nation or region, contributing to ADI's overarching global mission and strategic objectives.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Alzheimer's Disease International' leadership includes:
Alzheimer's Disease International has been backed by several prominent investors over the years, including:
Over the past 12-18 months, Alzheimer's Disease International has focused on strengthening its executive leadership, particularly in policy, campaigns, and communications with key appointments. Some roles have seen transitions, as indicated by interim leadership appointments, reflecting ongoing organizational development.
Discover the tools Alzheimer's Disease International uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Alzheimer's Disease International (ADI) generally utilizes a standardized email format for its staff members, which is common for professional organizations. The most frequently observed pattern is the first initial, followed by a period, and then the last name.
[first_initial].[last_name]@alzint.org
Format
j.doe@alzint.org
Example
85%
Success rate
alzint.org • February 12, 2024
ADI, in partnership with the Polish Alzheimer's Association, unveiled the program for its 36th Global Conference, scheduled for April 24-26, 2024, in Krakow, Poland. The event will gather global experts, researchers, individuals with dementia, and caregivers to exchange knowledge and discuss advancements in dementia research, care, and policy....more
alzint.org • January 24, 2024
Alzheimer's Disease International presented a statement at the 154th WHO Executive Board meeting, calling on member states to fully integrate dementia care, support, and risk reduction strategies within Universal Health Coverage (UHC) frameworks to ensure equitable access for people living with dementia and their families....more
alzint.org • September 21, 2023
ADI released its flagship World Alzheimer Report 2023, titled 'Reducing dementia risk: never too early, never too late.' The report highlights the crucial role of healthcare practitioners and governments in implementing comprehensive dementia risk reduction strategies and calls for urgent global action....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Alzheimer's Disease International, are just a search away.